Attention A T users. To access the menus on this page please perform the following steps.
1. Please switch auto forms mode to off.
2. Hit enter to expand a main menu option (Health, Benefits, etc).
3. To enter and activate the submenu links, hit the down arrow.
You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Locator
Contact
Search
Search
Menu
Diana Jalal, MD
Dr. Jalal is an Investigator at and the Associate Director of the Center for Access & Delivery Research and Evaluation (CADRE) at the Iowa City VA and an Associate Professor in the Nephrology Division of Internal Medicine at the University of Iowa Carver College of Medicine (Diana Jalal | Department of Internal Medicine ). As a nephrologist, she specializes in the care and research of chronic kidney disease (CKD).
Dr. Jalal graduated from The University of Jordan Faculty of Medicine in 1998, after which she completed her residency training in Internal Medicine at the University of Iowa. She then moved to Texas where she completed clinical fellowship training in Nephrology at Baylor College of Medicine and a research fellowship at the University of Texas- Houston. Dr. Jalal started her academic career as an Assistant Professor of Medicine at the University of Texas- Houston. She subsequently moved to the University of Colorado (Denver, Colorado) where she was an Associate Professor of Medicine and the Clinical Director for the Renal Service at the University of Colorado Hospitals. In 2017, she moved back to Iowa as an Associate Professor of Medicine at the University of Iowa Renal Division and the Deputy Chief of Specialty Medicine at the Iowa City VA HCS.
Education
MD University of Jordan, 1998
Post-grad University of Iowa, 1999-2002
Post-grad Baylor College of Medicine, 2002-2003
Post-grad University of Texas-Houston, 2003-2005 (Research Fellowship)
Research Interests:
- Vascular disease in CKD
- Hypertension
VA Research Projects
- Pharmacist-guided patient-driven self-management of hypertension in CKD: A novel approach
- The alternative complement pathway as a predictor of adverse kidney and cardiovascular outcomes in CKD
- Curcumin supplementation to improve vascular and cognitive function in CKD
